LetsGetChecked

Are you interested in staying on top of the latest health trends, insights, and innovations? Then sign up for our newsletter! At LetsGetChecked, we are dedicated to empowering your populations to take control of their health and well-being through accessible testing, virtual care, genetic sequencing, and medication delivery. Our newsletter has something for everyone. By subscribing, you'll gain access to: ✅ Exclusive content curated by health experts ✅ Updates on new testing options and services ✅ Inspiring stories from our community Join us on our mission to make proactive health management accessible to all by subscribing to our newsletter today: https://lnkd.in/gu23ktmE

Reliable lead screening is crucial for early detection of lead exposure in children. A LetsGetChecked study highlights the effectiveness of using dried blood spots (DBS) for this purpose, presenting a strong alternative to traditional venipuncture and capillary collection methods. Conducted across three independent clinical laboratories, the research compared three DBS inductively coupled plasma-mass spectrometry (ICP-MS) methods and found that using matrix-matched DBS calibrators significantly enhanced performance. The study demonstrated a strong correlation between lead levels measured in DBS and whole blood, affirming DBS ICP-MS as a robust and accurate method for lead screening. This advancement underscores the value of external quality control programs in evaluating DBS methods, making it a promising tool in pediatric health screening. Thank you Rogers A. Muldrow, one of our Research and Development Scientists, for your dedication and contribution to the publication of this study. Discover more here: https://lnkd.in/ejG_s7-Z

When we visited Novartis UK’s offices for a heart health presentation in support of British Heart Week, we provided their employees with complimentary heart health and Lipoprotein(a) screening to underscore the importance of taking charge of your heart health and identifying personal risks early on. Being aware of your Lp(a) levels and regularly testing your cholesterol levels is crucial in preventing cardiovascular disease and managing overall heart health effectively.

According to the study “At-Home Diagnostics Solutions for Chlamydia and Gonorrhea” by Ellen Kersh, PhD, D(ABMM) and Leandro Mena, STIs, particularly chlamydia and gonorrhea, remain significant public health challenges in the United States. Traditional testing methods often face barriers such as accessibility and stigma, leading to persistently low screening rates, especially in under-resourced areas. It was great to see our FDA DeNovo authorized Simple 2 Test, which tests for gonorrhea and chlamydia through vaginal swab or urine sample from at-home collection, highlighted as a solution to address some of these challenges. By removing the barriers to testing, we empower people to take control of their sexual health, ensuring timely detection and treatment of STIs, thereby contributing to better public health outcomes.

We are pleased to share an article co-authored by Dr. Avni Santani, our Chief Genomics Officer, and colleagues at Stanford University that explores the application of whole genome sequencing as a single platform for clinical constitutional genetic testing. As a result of continuous improvements in throughput and cost effectiveness, whole genome sequencing is rapidly becoming a platform of choice for comprehensive genetic testing. This review evaluates the utility of genome sequencing in a range of applications including diagnostic testing, carrier screening, prenatal testing, risk assessment  and cytogenomics. Discover more at the link below: https://lnkd.in/e6a2wB3m

A recently published study out of LetsGetChecked Labs outlines our in-house developed quality assurance workflow, which ensures the accuracy of testosterone testing using self-collected capillary samples. By reflexing total testosterone (TT) samples exceeding 1500 ng/dL to luteinizing hormone (LH) and follicle-stimulating hormone (FSH), we screened for exogenous testosterone use. Among 8,572 TT samples, 533 had elevated TT levels. Of these 533 elevated TT samples, 441 (82.7%) showed decreased LH/FSH levels, indicative of exogenous testosterone use. This workflow effectively differentiates between accurate and erroneous supraphysiological TT concentrations, enhancing the reliability and precision of our direct access testing (DAT) solutions. To read the complete study, click here: https://lnkd.in/ePhSwC4S

Give your employees the power to choose how they engage in their biometric screenings — at work, at home, or at the doctor’s office. With accessible screening options and actionable health insights from anywhere, you can support your workforce with the care they deserve. Learn more: https://lnkd.in/gE5T2Ye4 

Last week, our Chief Genomics Officer, Dr. Avni Santani, had the privilege of presenting at the Illumina Ventures 2024 Annual Meeting on the topic, "Healthcare Redefined: Innovative Delivery Models for Home and Beyond." In her session, Dr. Santani delved into how LetsGetChecked’s innovative delivery models are transforming healthcare, bringing chronic disease testing, genomic solutions, and care for millions of lives. She highlighted the critical role of home-based healthcare in improving patient outcomes, increasing accessibility, and driving personalized care. Thank you Illumina Ventures for the opportunity to share our vision and collaborate with industry leaders dedicated to reshaping the future of healthcare.

There’s still time to register for tomorrow’s webinar! Join us for an exciting conversation with Vitality on 2024 employer trends. Register here: https://lnkd.in/gBHpgGTS

We are thrilled to announce that we have been awarded a prestigious Red Dot Design Award in Product Design 2024 for our next-generation blood sample collection device, “LetsGetChecked ImPress.” Our patented upper-arm blood collection device adheres directly to the skin and uses gentle vacuum suction to extract up to 600uL of blood in minutes. Designed for at-home sample collection or clinical point-of-care settings, LetsGetChecked ImPress has the power to transform the blood collection process. This international recognition highlights our commitment to innovative design and exceptional functionality, empowering patients worldwide. A big thank you to our dedicated team and supporters for making this achievement possible!